Brad Burkett and JD Friedland have launched Match Point Partners, a strategy and financial advisory firm that helps healthcare and technology companies navigate through each phase of growth to maximise long-term value.
The firm’s team includes 12 entrepreneurs and advisers and provides a blend of experience that addresses the distinctive growth challenges of middle market and emerging companies, while applying a longer-term lens and financial resources typically available to companies only after a certain growth threshold.
“We founded Match Point Partners to provide middle market and emerging companies with a hybrid suite of advisory, operational and banking services, which typically have not been available to them,” says Brad Burkett (pictured), founder and senior managing director of Match Point Partners. “We’ve assembled an exceptional executive team that meshes expertise in strategy and management consulting, operations and financial advisory services, combined with a deep entrepreneurial mindset that is vital for middle market and emerging companies.”
Founded by two veterans with extensive advisory and operating experience, Burkett and Friedland were previously the managing partners at Epsilon Securities, a boutique investment bank focusing on middle-market companies. Prior to Epsilon, Friedland was the head of US healthcare investment banking for Rothschild North America, while Burkett was the head of healthcare investment banking for Navigant Capital Advisors.
“Match Point fills a void in the middle market, acting as a catalyst to assist executives at key inflection points with an eye always toward maximising long-term value,” says Friedland. “Whether it’s determining the optimal path forward through an analysis of a client’s strategic, operational and financial issues, or implementing the solution or transaction to help clients meet their financial and strategic objectives, we apply an entrepreneurial-centric mindset in creating a bridge for growth.”
In addition to its core services, Match Point brings valuable relationships with strategic and financial experts in the technology and healthcare sectors, as well as capital resources that enable the company to participate as an investor in select opportunities.
